Loading...
Loading...
JUPW| Name | Value |
|---|---|
| Revenues | -4,396.9K |
| Cost of Revenue | 3,588.2K |
| Gross Profit | -808.8K |
| Operating Expense | 7,633.0K |
| Operating I/L | -41,543.1K |
| Other Income/Expense | 0.0K |
| Interest Income | 57.1K |
| Pretax | 1,667.8K |
| Income Tax Expense | -1,304.4K |
| Net Income/Loss | 1,726.3K |
Jupiter Wellness, Inc. specializes in developing and commercializing cannabidiol (CBD) based medical therapeutics and wellness products. Their clinical pipeline includes CaniDermRX (JW-100) for eczema and dermatitis, JW-101 for burns, and JW-200 for cold sores. Additionally, the company manufactures and markets a range of consumer products such as CBD-infused sunscreen, skin care lotion, and dermatological treatments under the CaniSun, CaniSkin, and CaniDermRX brands. Their revenue is generated through the sale of these prescription and non-prescription products, catering to the growing demand for CBD-based treatments in the medical and wellness sectors.
